Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis

American Journal of Neuroradiology

Volumn 19, Issue 2, 1998, Pages 235-238

  Filippi, Massimo ^a,d   Rocca, Mara A ^a   Horsfield, Mark A ^b   Rovaris, Marco ^a   Pereira, C ^a   Yousry, Tarek A ^c   Colombo, B ^a   Comi, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY;

EID: 0032470862     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16
2. Filippi M, Miller DH. Magnetic resonance imaging (MRI) in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 1996;9:178-186
3. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 1995;118:1583-1592
4. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MR morphometry and magnetic resonance spectroscopy. Brain 1996;119:715-722
5. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67
6. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482
7. Filippi M, Barker GJ, Horsfield MA, et al. Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study. J Neurol 1994;241:246-251
8. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
9. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (black holes) on T1 spin- echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476
10. Filippi M, Campi A, Colombo B, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996; 243:502-505
11. Losseff NA, Webb SL, O'Riordan JI, Miller DH, Thompson AJ. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701-708
12. Filippi M, Horsfield MA, Campi A, Mammi S, Pereira C, Comi G. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-754
13. Filippi M, Yousry T, Horsfield MA, et al. A high- resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996;40:201-209
14. Mugler JP, Brookeman JR. Three-dimensional magnetization- prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15:152-157
15. Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted gradient-echo sequence: initial experience in the brain. Radiology 1992;182:769-775
16. Shah M, Ross JS, Van Dyke C, et al. Volume T1-weighted gradient echo MRI in multiple sclerosis patients. J Comput Tomogr 1992; 16:731-736
17. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452
19. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688
20. Filippi M, Horsfield MA, Bressi S, et al. Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis: a comparison of techniques. Brain 1995;118:1593-1600
21. Rovaris M, Yousry T, Calori G, Fesl G, Voltz R, Filippi M. Sensitivity and reproducibility of fast-FLAIR, FSE and TGSE sequences for the assessment of brain MRI lesion load in multiple sclerosis: a preliminary study. J Neuroimaging 1997;7:98-102
22. Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995;16:1473-1479
23. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994;36:S97-S99
24. van Walderveen MAA. Hypointense lesions on T1-weighted SE MR imgages correlate with axonal loss in multiple sclerosis. Presented at the annual meeting of the International Society for Magnetic Resonance in Medicine, Vancouver, Canada, April 1997.